Anti-CD20 Monoclonal Antibodies (MABs) Market Segmentation Detailed Study with Forecast to 2028 : Pfizer Inc, Hoffmann-La Roche Ltd.
There are various drugs available in the market for the treatment of diseases like cancer, autoimmune disorders, and various other neurological disorders.
View full press release